Episode

Signal over Noise: Playing offense and defense through healthcare

Podcast
UBS On-Air: Market Moves
Published
Jun 7, 2026
Duration seconds
337
Processing state
not_requested
Canonical source
https://www.ubs.com/content/dam/podcasts/wma/260607-signal-over-noise.mp3
Audio
https://www.ubs.com/content/dam/podcasts/wma/260607-signal-over-noise.mp3
JSON
/v1/public/podcasts/ubs-on-air-market-moves-2992243/episodes/signal-over-noise-playing-offense-and-defense-through-healthcare
Markdown
/podcast/ubs-on-air-market-moves-2992243/signal-over-noise-playing-offense-and-defense-through-healthcare.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/ubs-on-air-market-moves-2992243/episodes/signal-over-noise-playing-offense-and-defense-through-healthcare/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/ubs-on-air-market-moves-2992243/signal-over-noise-playing-offense-and-defense-through-healthcare.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Health care has not seen the same stock market traction as AI and power and resources over the past year, but continues to serve as a key ingredient to a diversified portfolio and a source of stability. This episode explores how the sector is not just a defensive play, with the pharma industry moving toward innovation-driven growth led by GLP-1 drugs. At the same time, advances in artificial intelligence and genomics are transforming how drugs are discovered, while an aging global population provides a powerful structural tailwind for demand.